When we prepped for our NY conference May 14-15, almost every speaker brought up something about being worried about tech. Nobody knows if we're headed towards enlightenment or dystopia. But it's become a main conference...
CVS agreed Sunday to buy Aetna for about $69 billion. Just a month ago, Aetna CEO Mark Bertolini recently sat down with David Kirkpatrick onstage at Techonomy 2017 and shared his vision for a new...
With Techonomy 2017 about to begin, Program Director Simone Ross surveys our panoply of topics and themes, from the "new hegemonist" net giants, to AI and jobs, AR & VR, the future of construction, the...
The American healthcare markethas undergone a period of rapid change in recent years. Chief among these changes has been a general shift towards consumer choice, prompting the rollout of new tech products in a bid...
It’s been a busy couple of weeks as we continue to fine-tune the program for September’s Techonomy Detroit. If you’re in Detroit September 15 you should stop by—we’ll be interviewing Mark Bertolini, the refreshing, bead...
Big and venerable companies around the world are increasingly confronting a vexing problem: They’re too big and venerable. The ironic truth: To get even bigger, they have to learn to act small. Executives increasingly believe...
Why has our rat-maze approach to coordinating care continued largely unchanged for more than 60 years? For all but the simplest of healthcare needs, we all find ourselves at some point trying to navigate a...
As 2013 winds down, Techonomy takes a moment to look back on highlights from the year, especially those that portend—we think—the future. Our Top Ten list recognizes the people, companies, and ideas that embodied how...
At Techonomy, we've argued from the beginning that there is no real difference between a "tech" company and a "company." We held a session entitled "Every Company is a Software Company" at our 2011 conference,...
